How is shingles contracted in individuals with a history of chickenpox, particularly in those over 50 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Shingles is Contracted

Shingles is not "contracted" from another person—it develops from reactivation of the varicella-zoster virus (VZV) that has been dormant in your nerve cells since you had chickenpox, triggered primarily by declining cell-mediated immunity. 1, 2

The Reactivation Mechanism

After you recover from chickenpox (which you do contract from others), the varicella-zoster virus doesn't leave your body—it establishes permanent latency in your sensory nerve ganglia (dorsal root ganglia). 1 The virus remains suppressed there for decades by your VZV-specific cellular immunity. 2 When this specific immune surveillance weakens sufficiently, the dormant virus reactivates, travels along the sensory nerve pathway, and erupts as the characteristic painful, unilateral dermatomal rash of shingles. 2, 3

Why Reactivation Occurs After Age 50

  • Age-related immunosenescence is the primary driver: Your VZV-specific cell-mediated immunity naturally declines with aging, which is why incidence rises sharply after age 50. 1, 2
  • Approximately 20-30% of people will develop shingles over their lifetime, with rates of 7-10 cases per 1,000 person-years after age 50. 1, 3
  • Nearly all adults over 50 harbor latent VZV—95-99% of adults in the U.S. have been infected with VZV and carry the virus capable of reactivation. 2

Additional Risk Factors for Reactivation

Beyond age, specific conditions accelerate the decline in VZV-specific immunity: 2, 3

  • Immunosuppressive conditions: HIV/AIDS (15-fold higher risk), diabetes mellitus, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease (risk ratios 1.23-2.08) 2, 3
  • Immunosuppressive medications: High-dose corticosteroids (≥7.5 mg/day prednisolone), JAK inhibitors (3-4 times higher risk), biologic DMARDs, chemotherapy 3
  • Other triggers: Psychological stress, ultraviolet light exposure, fever, recent COVID-19 infection 2, 3
  • Early childhood chickenpox: Children who had chickenpox during the first year of life have increased risk of childhood shingles 1

Important Distinction: Transmission FROM Shingles

While you cannot "catch" shingles from someone else, a person with active shingles can transmit VZV to susceptible individuals (those who never had chickenpox), causing chickenpox in them—not shingles. 1 The transmission risk from shingles lesions is approximately 20% of the risk from active chickenpox. 1 The infected person remains contagious from 1-2 days before rash onset until all lesions are crusted. 1, 2

Clinical Pitfall to Avoid

Do not confuse the mechanism of shingles development with chickenpox transmission. Chickenpox spreads person-to-person via direct contact, airborne droplets, or respiratory secretions with 80-90% attack rates in susceptible household contacts. 1 Shingles, however, is an endogenous reactivation—you're essentially being "infected" by your own latent virus when your immune system can no longer suppress it. 2, 3

Vaccine Considerations

Even individuals who received varicella vaccine (rather than natural chickenpox) harbor latent vaccine-strain VZV in their ganglia and remain at risk for shingles, though this risk appears lower than after wild-type infection. 1, 2 Vaccination with recombinant zoster vaccine (RZV) boosts VZV-specific T-cell immunity and is the most effective prevention strategy, reducing shingles incidence by 92% over 3.2 years. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Shingles Development and Reactivation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Herpes Zoster Reactivation Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vaccines for preventing herpes zoster in older adults.

The Cochrane database of systematic reviews, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.